• NICE backing for Astella's Xospata pharmatimes
    July 20, 2020
    NICE has recommended use of Astellas' Xospata (gilteritinib) for adults with relapsed or refractory FLT3 mutation-positive acute myeloid leukaemia (AML).
PharmaSources Customer Service